Development and validation of a risk prediction algorithm for evaluating the efficacy of postoperative adjuvant TACE therapy for hepatocellular carcinoma
CONCLUSION: This model may be an easy-to-use tool for screening patients suitable for PA-TACE treatment and guiding the selection of clinical protocols. But further research and external validation are required.PMID:37622693 | DOI:10.2174/1386207326666230824090204
Source: Combinatorial Chemistry and High Throughput Screening - Category: Chemistry Authors: Jie Tao Xiaoli Shi Xu Feng Xinhua Wu Shiguai Qi Guoying Feng Xu Yang Yufei Zhao Hangjia Zuo Zhengrong Shi Source Type: research
More News: Bilirubin | Cancer | Cancer & Oncology | Carcinoma | Chemistry | Child Development | Children | Cirrhosis | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver | Liver Cancer | Statistics | Study | Urology & Nephrology